BIOTECHNOLOGY VALUE FUND L P - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...11, 12, 13, 14, 15, 16, 17, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-07-12
4:40 pm
Purchase
2022-07-0813GESSA Pharma Inc.
EPIX
BIOTECHNOLOGY VALUE FUND L P8,748,629
19.900%
4,183,387increase
(+91.64%)
Filing
History
2022-07-11
5:03 pm
Purchase
2022-06-2913G89bio, Inc.
ETNB
BIOTECHNOLOGY VALUE FUND L P3,898,000
9.990%
3,898,000increase
(New Position)
Filing
History
2022-06-21
4:53 pm
Purchase
2022-06-1613G4D Molecular Therapeutics, Inc.
FDMT
BIOTECHNOLOGY VALUE FUND L P4,007,413
12.400%
2,001,551increase
(+99.79%)
Filing
History
2022-06-16
5:24 pm
Purchase
2022-06-0613GCentessa Pharmaceuticals plc
CNTA
BIOTECHNOLOGY VALUE FUND L P6,894,345
7.300%
6,894,345increase
(New Position)
Filing
History
2022-06-06
5:25 pm
Purchase
2022-06-0213GRepare Therapeutics Inc.
RPTX
BIOTECHNOLOGY VALUE FUND L P8,141,988
19.400%
3,283,227increase
(+67.57%)
Filing
History
2022-06-01
5:00 pm
Purchase
2022-05-2713DKymera Therapeutics, Inc.
KYMR
BIOTECHNOLOGY VALUE FUND L P4,138,758
8.000%
552,100increase
(+15.39%)
Filing
History
2022-05-26
5:09 pm
Purchase
2022-05-1613GAnnexon, Inc.
ANNX
BIOTECHNOLOGY VALUE FUND L P3,343,194
8.700%
3,343,194increase
(New Position)
Filing
History
2022-05-02
5:02 pm
Purchase
2022-04-2213GiTeos Therapeutics, Inc.
ITOS
BIOTECHNOLOGY VALUE FUND L P1,929,201
5.400%
1,929,201increase
(New Position)
Filing
History
2022-05-02
4:59 pm
Purchase
2022-04-2213GIDEAYA Biosciences, Inc.
IDYA
BIOTECHNOLOGY VALUE FUND L P1,964,859
5.100%
1,964,300increase
(+351395.35%)
Filing
History
2022-04-18
4:49 pm
Purchase
2022-04-0513DMoonLake Immunotherapeutics
MLTX
BIOTECHNOLOGY VALUE FUND L P21,751,284
58.900%
21,751,284increase
(New Position)
Filing
History
2022-04-04
4:38 pm
Purchase
2022-03-2513GAN2 Therapeutics, Inc.
ANTX
BIOTECHNOLOGY VALUE FUND L P1,616,665
8.600%
1,616,665increase
(New Position)
Filing
History
2022-03-24
4:22 pm
Purchase
2022-03-1413GTyra Biosciences, Inc.
TYRA
BIOTECHNOLOGY VALUE FUND L P2,472,327
5.900%
2,472,327increase
(New Position)
Filing
History
2022-03-18
7:18 pm
Sale
2021-12-3113GXenon Pharmaceuticals Inc.
XENE
BIOTECHNOLOGY VALUE FUND L P4,305,540
8.200%
-851,946decrease
(-16.52%)
Filing
History
2022-03-14
4:48 pm
Purchase
2022-03-0313GArcus Biosciences, Inc.
RCUS
BIOTECHNOLOGY VALUE FUND L P3,960,948
5.600%
1,208,726increase
(+43.92%)
Filing
History
2022-02-14
2:01 pm
Sale
2021-12-3113GInfinity Pharmaceuticals, Inc.
INFIQ
BIOTECHNOLOGY VALUE FUND L P6,353,645
7.100%
-2,030,000decrease
(-24.21%)
Filing
History
2022-02-14
1:56 pm
Purchase
2021-12-3113GPieris Pharmaceuticals, Inc.
PIRS
BIOTECHNOLOGY VALUE FUND L P92,583
9.990%
22,563increase
(+32.22%)
Filing
History
2022-02-14
1:53 pm
Purchase
2021-12-3113GXenon Pharmaceuticals Inc.
XENE
BIOTECHNOLOGY VALUE FUND L P5,157,486
9.990%
1,658,140increase
(+47.38%)
Filing
History
2022-02-14
1:51 pm
Purchase
2021-12-3113GViridian Therapeutics, Inc.
VRDN
BIOTECHNOLOGY VALUE FUND L P2,202,315
9.990%
2,202,315increase
(New Position)
Filing
History
2022-02-14
1:49 pm
Purchase
2021-12-3113GPHAXIAM Therapeutics S.A.
PHXM
BIOTECHNOLOGY VALUE FUND L P51,192
16.500%
10,372increase
(+25.41%)
Filing
History
2022-02-14
1:46 pm
Purchase
2021-12-3113GElevation Oncology, Inc.
ELEV
BIOTECHNOLOGY VALUE FUND L P1,611,698
6.900%
1,611,698increase
(New Position)
Filing
History
Goto Prev, 0, 1, ...11, 12, 13, 14, 15, 16, 17, Next